Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter Jelle Visser

Showing results (1-10 of 340) with videos related to

Pageof 34
Sort By:
Journal of the American Geriatrics Society|January 3, 2007
Mild cognitive impairment subtypes and vascular dementiaPieter Jelle Visser
International Psychogeriatrics|September 27, 2006
MCI is not a clinically useful conceptPieter Jelle Visser, Henry Brodaty
JAMA|June 14, 2017
Brain Amyloid Pathology and Cognitive Function: Alzheimer Disease Without Dementia?Pieter Jelle Visser, Betty Tijms
Biomarkers in Medicine|August 25, 2012
Fluid biomarkers for Alzheimer's disease: standardization and recent developmentsHenrik Zetterberg, Pieter Jelle Visser
Neurology|July 31, 2009
Amyloid imaging in the prediction of Alzheimer-type dementia in subjects with amnestic MCIPieter Jelle Visser, David S Knopman
The Lancet. Neurology|July 4, 2015
Biomarkers for Alzheimer's disease: a controversial topicGiovanni B Frisoni, Pieter Jelle Visser
The Lancet. Neurology|February 5, 2018
Capturing the Alzheimer's disease pathological cascadeBetty M Tijms, Pieter Jelle Visser
Brain : a Journal of Neurology|May 26, 2018
Chasing the start of sporadic Alzheimer's disease running in familiesBetty M Tijms, Pieter Jelle Visser
Journal of Alzheimer'S Disease : JAD|June 6, 2018
Preclinical Alzheimer's Disease: Implications for Refinement of the ConceptStephanie J B Vos, Pieter Jelle Visser
Alzheimer'S Research & Therapy|April 15, 2010
Can novel therapeutics halt the amyloid cascade?Niels D Prins, Pieter Jelle Visser, Philip Scheltens
Pageof 34

Showing results (1-10 of 340) with videos related to

Sort By:
Pageof 34
Journal of the American Geriatrics Society|January 3, 2007
Mild cognitive impairment subtypes and vascular dementiaPieter Jelle Visser
International Psychogeriatrics|September 27, 2006
MCI is not a clinically useful conceptPieter Jelle Visser, Henry Brodaty
JAMA|June 14, 2017
Brain Amyloid Pathology and Cognitive Function: Alzheimer Disease Without Dementia?Pieter Jelle Visser, Betty Tijms
Biomarkers in Medicine|August 25, 2012
Fluid biomarkers for Alzheimer's disease: standardization and recent developmentsHenrik Zetterberg, Pieter Jelle Visser
Neurology|July 31, 2009
Amyloid imaging in the prediction of Alzheimer-type dementia in subjects with amnestic MCIPieter Jelle Visser, David S Knopman
The Lancet. Neurology|July 4, 2015
Biomarkers for Alzheimer's disease: a controversial topicGiovanni B Frisoni, Pieter Jelle Visser
The Lancet. Neurology|February 5, 2018
Capturing the Alzheimer's disease pathological cascadeBetty M Tijms, Pieter Jelle Visser
Brain : a Journal of Neurology|May 26, 2018
Chasing the start of sporadic Alzheimer's disease running in familiesBetty M Tijms, Pieter Jelle Visser
Journal of Alzheimer'S Disease : JAD|June 6, 2018
Preclinical Alzheimer's Disease: Implications for Refinement of the ConceptStephanie J B Vos, Pieter Jelle Visser
Alzheimer'S Research & Therapy|April 15, 2010
Can novel therapeutics halt the amyloid cascade?Niels D Prins, Pieter Jelle Visser, Philip Scheltens
Pageof 34